William W Wong | OMICS International

OMICS Journal of Radiology
Open Access

Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

William W Wong

William W Wong is working as an Associate Professor of Radiation Oncology for  


Dr. William Wong is a radiation oncologist in Scottsdale, Arizona and is affiliated with Mayo Clinic. He received his medical degree from University of Chicago Pritzker School of Medicine and has been in practice for 29 years. Dr. Wong accepts several types of health insurance, listed below. He is one of 9 doctors at Mayo Clinic who specialize in Radiation Oncology. He also speaks multiple languages, including Chinese (Cantonese) and Chinese (Mandarin).

Research Interest

His clinical practice and research interests are focused in the management of genito-urinary and breast cancers.

For patients with prostate cancer, the use of intensity modulated radiation therapy (IMRT) and image-guided radiation therapy (IGRT) have become the standard of care.

His team is evaluating the integration of prostate MRI scan into our treatment planning to target areas of abnormal signal to higher doses of radiation. The goals are to achieve better cancer control while minimizing side effects to surrounding normal tissues.

They were the first group to evaluate the use of indium-111 capromab pendetide imaging to guide dose escalation for prostate cancer.

For breast cancer, he and his colleagues have performed studies evaluating the use of intra-operative irradiation to the tumor bed as a boost after lumpectomy followed by whole breast irradiation for early-stage breast cancer. Hypo-fractionated dose scheme has also been integrated into our practice for external beam irradiation after lumpectomy.